Skip to content

Nasal high - flow - oxygen therapy in patients with hypoxic respiratory failure: Effect on functional and subjective respiratory parameters compared to conventional O2 therapy and non-invasive ventilation (NIV)

Nasal high - flow - oxygen therapy in patients with hypoxic respiratory failure: Effect on functional and subjective respiratory parameters compared to conventional O2 therapy and non-invasive ventilation (NIV) - Highox

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005132
Enrollment
14
Registered
2013-07-08
Start date
2009-03-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J96.0 J18.9

Interventions

Group 1: The assignment of patients to the order in which the three oxygen applicators is applied will be randomized. Each intervention is preceded by a 15-minute baseline period, in which oxygen is a

Sponsors

Universitätsklinikum Tübingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age > 18 years, signs of acute respiratory failure (tachypnea, dyspnea) with paO2 < 55 mmHg under room air

Exclusion criteria

Exclusion criteria: - cardiac pulmonary edema - COPD and /or ventilatory failure - hemodynamic instability - contraindications to NIV - impaired consciousness or desorientation - inability to give informed consent.

Design outcomes

Primary

MeasureTime frame
At the end of each 30 min intervention phase the following primary endpoints are measured: •Respiratory rate •Arterial oxygen partial pressure (paO2) •Dyspnea (10 point numeric Borg – Scale) •Patient comfort (10 point numeric scale) At the end of the investigation the patients rate all three devices using German school grades (1=very good, 6= failed) und can choose one device for further treatment.

Secondary

MeasureTime frame
At the end of each 30 min intervention phase the following secondary endpoints are measured: • Arterial CO2 partial pressure (paCO2) • Heart rate • Blood pressure • Peripheral oxygen saturation (SpO2)

Countries

Germany

Contacts

Public ContactReimer Riessen

Internistische Intensivstation93 Department für Innere Medizin Universitätsklinikum Tübingen

reimer.riessen@med.uni-tuebingen.de07071-2983469

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 19, 2026